The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Targeting Th17 cells in autoimmune diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191
Induction and molecular signature of pathogenic TH17 cells
Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2416 · Cited by 1,174
A Validated Regulatory Network for Th17 Cell Specification
Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkurst, C. N., Muratet, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.016 · Cited by 1,160
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K., O'Shea, J. J., & Cua, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1698 · Cited by 1,074
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 848
McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., Brodmerkel, C., Li, S., Wang, Y., Mendelsohn, A. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60594-2 · Cited by 807
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Lubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
Jetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 673
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
Huh, J. R., Leung, M. W. L., Huang, P., Ryan, D. A., Krout, M. R., Malapaka, R. R. V., Chow, J., Manel, N., Ciofani, M., Kim, S. V., et al. (2011) · Nature · doi:10.1038/nature09978 · Cited by 536
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
Solt, L. A., Kumar, N., Nuhant, P., Wang, Y., Lauer, J. L., Liu, J., Istrate, M. A., Kamenecka, T. M., Roush, W. R., Vidović, D., et al. (2011) · Nature · doi:10.1038/nature10075 · Cited by 508
Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12110 · Cited by 360
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Xiao, S., Yosef, N., Yang, J., Wang, Y., Zhou, L., Zhu, C., Wu, C., Baloglu, E., Schmidt, D., Ramesh, R., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.004 · Cited by 276
Self-citationIncreased Circulating Pro-Inflammatory Cytokines and Th17 Lymphocytes in Hashimoto’s Thyroiditis
Figueroa-Vega, N., Alfonso-Pérez, M., Benedicto, I., Sánchez-Madrid, F., González-Amaro, R., & Marazuela, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1719 · Cited by 266
Kumar, N., Solt, L. A., Conkright, J. J., Wang, Y., Istrate, M. A., Busby, S. A., Garcia-Ordonez, R. D., Burris, T. P., & Griffin, P. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.060905 · Cited by 236
Xu, T., Wang, X., Zhong, B., Nurieva, R. I., Ding, S., & Dong, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.250407 · Cited by 227
Action of RORs and their ligands in (patho)physiology
Solt, L. A., & Burris, T. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.012 · Cited by 197
IL‐23: One cytokine in control of autoimmunity
Croxford, A. L., Mair, F., & Becher, B. (2012) · European Journal of Immunology · doi:10.1002/eji.201242598 · Cited by 193
Koenders, M. I., Kolls, J. K., Oppers‐Walgreen, B., Van Den Bersselaar, L., Joosten, L. A. B., Schurr, J. R., Schwarzenberger, P., Van Den Berg, W. B., & Lubberts, E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21342 · Cited by 186
Association of interleukin‐23 receptor variants with ankylosing spondylitis
Rahman, P., Inman, R. D., Gladman, D. D., Reeve, J. P., Peddle, L., & Maksymowych, W. P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23389 · Cited by 181
Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Fauber, B. P., & Magnuson, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401901d · Cited by 165
Lubberts, E., Joosten, L. A. B., van de Loo, F. A. J., Schwarzenberger, P. O., Kolls, J., & van den Berg, W. B. (2002) · Inflammation Research · doi:10.1007/bf02684010 · Cited by 152
Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator
Kumar, N., Lyda, B. R., Chang, M. R., Lauer, J. L., Solt, L. A., Burris, T. P., Kamenecka, T. M., & Griffin, P. R. (2012) · ACS Chemical Biology · doi:10.1021/cb200496y · Cited by 147
Skepner, J. E., Ramesh, R., Trocha, M., Schmidt, D. R., Baloglu, E., Lobera, M., Carlson, T. J., Hill, J. A., Orband‐Miller, L. A., Barnes, A. A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302190 · Cited by 143
Self-citationFujita-Sato, S., Ito, S., Isobe, T., Ohyama, T., Wakabayashi, K., Morishita, K., Ando, O., & Isono, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254003 · Cited by 142
Huber, A. K., Jacobson, E. M., Jażdżewski, K., Concepcion, E., & Tomer, Y. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2190 · Cited by 137
Effective treatment of rat adjuvant-induced arthritis by celastrol
Cascão, R., Vidal, B., Raquel, H., Neves‐Costa, A., Figueiredo, N., Gupta, V., Fonseca, J. E., & Moita, L. F. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.022 · Cited by 119
Martin, D. A., Churchill, M. A., Flores-Suárez, L. F., Cardiel, M. H., Wallace, D. J., Martin, R. W., Phillips, K., Kaine, J., Dong, H., Salinger, D. H., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4347 · Cited by 111
Chang, M. R., Lyda, B. R., Kamenecka, T. M., & Griffin, P. R. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38272 · Cited by 98
Th17 cells in autoimmune demyelinating disease
Segal, B. M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0186-z · Cited by 95
Targeting IL-17 and Th17 cells in rheumatoid arthritis.
Sarkar, S., & Fox, D. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.02.006 · Cited by 91
Targan, S. R., Feagan, B. G., Vermeire, S., Panaccione, R., MELMED, G. Y., Blosch, C. M., Newmark, R., Zhang, N., Chon, Y., Lin, S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.084 · Cited by 88
Association of Interleukin 23 Receptor Variants with Psoriatic Arthritis
Rahman, P., Inman, R. D., Maksymowych, W. P., REEVE, J. P., Peddle, L., & Gladman, D. D. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080458 · Cited by 83
Solt, L. A., Kumar, N., He, Y., Kamenecka, T. M., Griffin, P. R., & Burris, T. P. (2012) · ACS Chemical Biology · doi:10.1021/cb3002649 · Cited by 77
Wen, S., Liu, G.-J., Feng, R., Gong, F.-C., Zhong, H., Duan, S., & Bi, S. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.004 · Cited by 76
Clinical Consequences of Targeting IL-17 and TH17 in Autoimmune and Allergic Disorders
Robinson, K. M., Manni, M. L., Biswas, P. S., & Alcorn, J. F. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0361-0 · Cited by 42
Role of Interleukin-23 (IL-23) Receptor Signaling for IL-17 Responses in Human Lyme Disease
Oosting, M., ter Hofstede, H. J. M., van de Veerdonk, F. L., Sturm, P., Kullberg, B. J., van der Meer, J. W. M., Netea, M. G., & Joosten, L. A. B. (2011) · Infection and Immunity · doi:10.1128/iai.05242-11 · Cited by 40
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
The Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
Zhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy182 · Cited by 525
Kaymaz, K., & Beikler, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143394 · Cited by 534
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Romano, M., Fanelli, G., Albany, C. J., Giganti, G., & Lombardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00043 · Cited by 512
Metadata
- Authors
- Yang, J., Sundrud, M. S., Skepner, J., & Yamagata, T.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 35
- Issue
- 10
- Pages
- 493-500
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2058487327
- Cited by
- 348
- References
- 59
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.